C3orf14: A Potential Drug Target and Biomarker (G57415)

Target Name: C3orf14

NCBI ID: G57415

C3orf14

C3orf14: A Potential Drug Target and Biomarker

C3orf14, also known as C3orf14 variant 1, is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the C3 domain family, which is known for its role in protein- protein interactions and regulation of cellular processes. C3orf14 has been identified as a potential drug target and biomarker due to its unique structure and the involvement of several diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

The C3 domain is a conserved region that is found in many proteins, including proteins involved in signaling pathways, protein-protein interactions, and intracellular signaling. The C3 domain is known for its ability to form a stable interaction with other proteins, either through direct contact or through the formation of a disulfide bond. This interaction between proteins is important for the regulation of cellular processes, including cell signaling, DNA replication, and protein-protein interactions.

C3orf14 is a 14-kDa protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the C3 domain family and has been identified as a potential drug target due to its unique structure and the involvement of several diseases.

One of the key features of C3orf14 is its unique structure. C3orf14 has a distinct N-terminus that is rich in amino acids, as well as a C-terminus that is involved in protein-protein interactions. The N-terminus of C3orf14 contains a unique structural domain that is known as the N-terminal domain. This domain is rich in amino acids, including four conserved acids that are involved in the formation of a stable interaction with other proteins.

The C3 domain is also known for its ability to form a stable interaction with other proteins through the formation of a disulfide bond. This interaction between proteins is important for the regulation of cellular processes, including cell signaling, DNA replication, and protein-protein interactions.

The involvement of C3orf14 in several diseases has also made it a potential biomarker. For example, C3orf14 has been identified as a potential drug target for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These diseases are characterized by the progressive loss of brain cells and the development of severe cognitive and motor impairments.

C3orf14 has also been identified as a potential biomarker for cancer, including breast, ovarian, and colorectal cancers. These diseases are characterized by the rapid and uncontrolled growth of cancer cells, leading to the development of serious health problems.

In addition to its potential as a drug target and biomarker, C3orf14 is also of interest to researchers as a potential therapeutic agent. The unique structure of C3orf14 makes it a potential target for small molecules, antibodies, or other therapeutic agents that can modulate its activity . For example, researchers have shown that small molecules can interact with the C3 domain of C3orf14 to modulate its activity, suggesting that C3orf14 may be a promising target for therapeutic agents.

In conclusion, C3orf14 is a protein that has been identified as a potential drug target and biomarker due to its unique structure and the involvement of several diseases. The C3 domain is known for its ability to form a stable interaction with other proteins, which is important for the regulation of cellular processes. Further research is needed to fully understand the potential of C3orf14 as a drug target and biomarker, as well as its potential as a therapeutic agent.

Protein Name: Chromosome 3 Open Reading Frame 14

The "C3orf14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C3orf14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets